Skip to main content

Pine Pollen Mix

NDC 22840-9434 · Greer Laboratories, Inc.

Generic namePinus taeda, Pinus strobus and Pinus echinata
Dosage formSOLUTION
RouteINTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
Active ingredient(s)PINUS ECHINATA POLLEN, PINUS TAEDA POLLEN, PINUS STROBUS POLLEN
Strength.0333333; .0333333; .0333333 g/mL; g/mL; g/mL
Pharmacologic classAllergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]
Marketing categoryBLA

Packages

22840-9434-2 — 10 mL in 1 VIAL, MULTI-DOSE (22840-9434-2)

22840-9434-4 — 50 mL in 1 VIAL, MULTI-DOSE (22840-9434-4)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

22840-3446 — Pinus taeda, 22840-3457 — Pinus strobus, 22840-3458 — Pinus strobus, 22840-3459 — Pinus strobus, 22840-3465 — Pinus echinata, 22840-3466 — Pinus echinata, 22840-3467 — Pinus echinata, 22840-4480 — Pinus strobus, 22840-4481 — Pinus strobus, 22840-5461 — Pinus taeda, 22840-5465 — Pinus strobus, 22840-5467 — Pinus echinata, 22840-9435 — Pinus taeda, Pinus strobus and Pinus echinata, 22840-9436 — Pinus taeda, Pinus strobus and Pinus echinata, 22840-9437 — Pinus taeda, Pinus strobus and Pinus echinata, 22840-9439 — Pinus taeda, Pinus strobus and Pinus echinata, 22840-9440 — Pinus taeda, Pinus strobus and Pinus echinata, 49643-388 — Pinus strobus, 49643-448 — Pinus echinata, 49643-524 — Pinus echinata/Pinus ponderosa/Pinus strobus, +8 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels